HR+/HER2- BREAST CANCER

Clinical trials for HR+/HER2- BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new HR+/HER2- BREAST CANCER trials appear

Sign up with your email to follow new studies for HR+/HER2- BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 7 Not yet recruiting 4 Not yet finished but already full! 1

New hope for advanced breast cancer: experimental drug takes on chemo

Disease control Ongoing

This study tests a new drug called BL-B01D1 against standard chemotherapy for people with advanced HR+HER2- breast cancer that has stopped responding to previous treatments. About 383 adults will be randomly assigned to receive either the new drug or a doctor-chosen chemo. The go…

Matched conditions: HR+/HER2- BREAST CANCER

Phase: PHASE3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated May 11, 2026 20:40 UTC

HR+/HER2- BREAST CANCER

Get alerted when new HR+/HER2- BREAST CANCER trials appear

New hope for advanced breast cancer: experimental drug takes on chemo